1 / 12

Hemostatic System - general information

Hemostatic System - general information. Normal hemostatic system vessel wall circulating blood platelets blood coagulation and fibrynolysis Platelets Anucleate disc-shape cell fragments arise from megakariocytes in bone marrow 1/3 of platelets are sequestrated in the spleen

galia
Download Presentation

Hemostatic System - general information

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Hemostatic System - general information • Normal hemostatic system • vessel wall • circulating blood platelets • blood coagulation and fibrynolysis • Platelets • Anucleate disc-shape cell fragments • arise from megakariocytes in bone marrow • 1/3 of platelets are sequestrated in the spleen • other 2/3 circulate for 7-10 days • responsible for primary hemostasis- they adhere to damaged blood vessels, aggregate one with another and facilitate the generation of thrombin • normal platelet count : 150-450 G/l

  2. Bleeding Diathesis • Is caused by inherited or acquired defects of • vessel wall • platelets number and/or function • coagulation system • Is characterised by • spontaneous bleeding • extensive bleeding after minimal trauma

  3. Platelets Disorder • Disorder of platelet number • thrombocytopenia • thrombocytosis • Disorder of platelet function

  4. Disorder of platelets function • defects of platelet adhesion • inherited: vonWillebrandt’s disease , Bernard-Soulier syndrome • acquired: uremia • defects of platelet aggregation • inherited: Glantzmann’s thrombasthenia • acquired: dysproteinemia, drug ingestion (ticlopidin) • defects of platelet release • inherited: grey-platelet, Hermansky-Pudlak,Chediac-Higashi syndr. • acquired: cardiopulmonary bypass, myeloproliferative disorders, drugs

  5. Thrombocytosis • Thrombocytosis resulting from myeloproliferation • essential thrombocythemia • polycythemia vera • chronic myelogenous leukemia • myeloid metaplasia • Secondary (reactive) thrombocytosis • systemic inflammation • malignancy • iron deficiency • hemorrhage • postsplenectomy

  6. Thrombocytopenia (1) Decreased marrow production of megakariocytes • congenital disorders • thrombocytopenia with absent radii (TAR) • Fanconi’s anemia • acquired disorders • marrow infiltration with malignant cells • marrow fibrosis • aplastic and hypoplastic anemias ( idiopathic, drugs, toxins ) • deficiency states ( vitamin B12, folate, iron ) • paroxysmal nocturnal hemoglobinuria

  7. Thrombocytopenia (2) Splenic sequestration of circulating platelets • splenic enlargement due to tumor infiltration • splenic enlargement due to portal hypertension

  8. Thrombocytopenia (3) Increased destruction of circulating platelets • congenital disorder • Wiscott-Aldrich syndrome, Bernard-Soulier syndrome • acquired disorders nonimmune destruction • vascular prostheses, cardiac valves • DIC • hemolytic-uremic syndrome/thrombotic thrombocytopenic purpura • sepsis immune destruction • idiopathic thrombocytopenic purpura ( ITP ) acute and chronic • drug-induced thrombocytopenia • chronic autoimmune disorders • infection (HIV) • malignancies

  9. Platelets Disorder - signs and symptoms • asymptomatic if platelets count > 50 G/l • onset of bleeding after trauma - immediate • site of bleeding - superficial: skin, mucous membranes, nose, genitourinary tract • physical finding - petechiae, ecchymoses

  10. Idiopathic Thrombocytopenic Purpura (1) • the most common cause of isolated thrombocytopenia • autoimmune disease with antiplatelet antibodies and shortened platelets life span • forms of ITP acute ITP • children (90% of pediatric case of immune thrombocytopenia) • preceded by viral infection • spontaneous recovery within 4-6 weeks in 60% of patients chronic ITP • 20-40 years • women predominance F:M=3:1

  11. Idiopathic Thrombocytopenic Purpura (2) • Clinical features • petechiae • ecchymoses • mucose membranes bleeding • menorrhagia • rare internal, intracranial bleeding • Diagnosis • platelet count <100G/l • bleeding time - usually normal • peripheral blood smear - large platelets • bone marrow examination - normal or increased number of megakariocytes • antibodies against Gp IIb/IIIa • shortened platelet survival

  12. Treatment of ITP • not necessary unless platelets count > 20G/L or there is extensive bleeding • corticosteroids permanent responses - 30% • prednisone 1mg/kg for 4-6 weeks • splenectomy permanent responses - 60% • immunosuppresive drugs • intravenous immunoglobulins • other - danazol

More Related